Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
DITEST is an oral formulation of native testosterone for the treatment of androgen deficiency in men. The study was a Phase 1 clinical study in hypogonadal men, defined according to FDA and Endocrine Society Guidelines, designed to evaluate the pharmacokinetic (PK) characteristics of DITEST, and to assess the safety and tolerability of DITEST in the target population.
Epistemonikos ID: 2aebbe51abb6b53a87fd169ec04167ded5431862
First added on: May 20, 2024